GenEdit Alternatives & Competitors
12 companies similar to GenEdit — Delivering the potential of genetic medicines
Companies similar to GenEdit
Aera Therapeutics
Enabling the next generation of transformative genetic medicines
Cambridge, United States
NanoVation Therapeutics™
Delivering tomorrow's genetic medicines, today™
Canada
ReCode Therapeutics
Powering the next wave of genetic medicines through superior delivery
United States
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Track all GenEdit competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they...
Philadelphia, United Stat...
Carbon Biosciences
Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
Boston, United States
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
Monrovia, United States
ReNAgade Therapeutics
RNA Without Limits
Cambridge, United States
Laronde
Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)
Cambridge, United States
Poseida Therapeutics, Inc.
A Member of the Roche Group
San Diego, United States
Capstan Therapeutics
Advancing cell engineering to develop therapeutics for a broad range of diseases
Anjarium Biosciences AG
DNA to Catalyze Your Advanced Therapies
Schlieren, Switzerland
About GenEdit
GenEdit, a biotechnology startup founded in 2016 and headquartered in the United States, is pioneering solutions in the realm of genetic medicines with its innovative slogan: "Delivering the potential of genetic medicines". The company addresses a critical bottleneck in the field—effective delivery systems for genetic...
Development of Precision Genetic Medicines, Targeted Delivery of Genetic Payloads, Restoration of Immune Balance, Pipeline for Autoimmune and Oncology Therapies
Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies
Genetic Medicines, Gene Therapy Delivery, Polymer Nanoparticles, Non-Viral Gene Editing, Therapeutic Candidates, NanoGalaxy Platform, Target Tissue Delivery, Gene Therapy Innovation, Non-Lipid Nanoparticles, Therapeutic Gene Editing, High Unmet Medical Need, Iterative Screening Process, Non-Viral Therapeutics, Genetic Disease Treatment, Safer Gene Editing
B2B, Platform
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches GenEdit and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at GenEdit on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
